Skip to main content
Top
Published in: Infectious Agents and Cancer 1/2016

Open Access 01-12-2016 | Research Article

Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana

Authors: A. K. Awua, S. T. Sackey, Y. D. Osei, R. H. Asmah, E. K. Wiredu

Published in: Infectious Agents and Cancer | Issue 1/2016

Login to get access

Abstract

Background

Human Papillomavirus (HPV) infections have been shown to be a necessary risk factor for the development of cervical cancer. However, HPV genotype distribution varies geographically, both in type and relative prevalence. In order to ensure a successful introduction of available vaccines, there is the need to identify pre-vaccination HPV genotype prevalence in Ghana and the extent of single and multiple-infections.

Methods

Paraffin-embedded cervical tissues of 256 confirmed cervical cancer cases diagnosed at the Korle-Bu Teaching Hospital during the period January 2004 to December 2006 were selected after hematoxylin and eosin staining and confirmation. Following a heat-proteinase K-based tissue lysis, HPV was detected and typed by a nested-multiplex PCR assay using an E6/E7 consensus primer and type-specific primers.

Results

Of the 256 cases, 230 (89.8 %, 95 % CI 85.7–93.4 %) were positive for HPV DNA. HPV18 (47.4 %), HPV59 (42.2 %), HPV45 (37.4 %) and HPV16 (9.0 %) were the four common HPV genotypes detected. A total of 110 (47.8 %) of the 230 HPV DNA positive tissues, were infected by a single HPV genotype while the other 120 (52.2 %) were infected by multiple HPV genotypes. A significant association was determined between each of the following HPV genotypes and multiple-infection; HPV18 (OR = 6.97; 95 % CI, 3.89–12.50), HPV59 (OR = 9.56; 95 % CI, 5.57–20.02) and HPV45 (OR = 1.94; 95 % CI, 1.12–3.35).

Conclusion

The prevalence of the following high risk HPV genotypes (HPV18, HPV59, HPV45) were relatively high among the cases of cervical cancers reported at this hospital in Ghana during the study period. Additionally, there was a high frequency of HPV multiple-infections among these cases.
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.PubMedCrossRef
2.
go back to reference Nkyekyer K. Pattern of gynaecological cancers in Ghana. East Afr Med J. 2000;77(10):534–8.PubMed Nkyekyer K. Pattern of gynaecological cancers in Ghana. East Afr Med J. 2000;77(10):534–8.PubMed
4.
go back to reference Takubo K, Shimomura-Izumiyama N, Koiwai H, Honma N, Esaki Y, Yoshida T, et al. Detection of human papillomavirus infection of the cervix in very elderly women using PCR. Clin Cancer Res. 2005;11(8):2919–23.PubMedCrossRef Takubo K, Shimomura-Izumiyama N, Koiwai H, Honma N, Esaki Y, Yoshida T, et al. Detection of human papillomavirus infection of the cervix in very elderly women using PCR. Clin Cancer Res. 2005;11(8):2919–23.PubMedCrossRef
5.
go back to reference Cañadas MP, Bosch FX, Junquera ML, Ejarque M, Font R, Ordoñez E, et al. Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population. J Clin Microbiol. 2004;42(3):1330–2.PubMedPubMedCentralCrossRef Cañadas MP, Bosch FX, Junquera ML, Ejarque M, Font R, Ordoñez E, et al. Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population. J Clin Microbiol. 2004;42(3):1330–2.PubMedPubMedCentralCrossRef
6.
go back to reference Lin H-P, Huang Y-Y, Wu H-Y, Kao J-T. Method for testing for human papillomavirus infection in patients with cervical intraepithelial disease. J Clin Microbiol. 2004;42(1):366–8.PubMedPubMedCentralCrossRef Lin H-P, Huang Y-Y, Wu H-Y, Kao J-T. Method for testing for human papillomavirus infection in patients with cervical intraepithelial disease. J Clin Microbiol. 2004;42(1):366–8.PubMedPubMedCentralCrossRef
7.
go back to reference Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–65.PubMedPubMedCentralCrossRef Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–65.PubMedPubMedCentralCrossRef
8.
go back to reference Baussano I, Franceschi S, Gillio-Tos A, Carozzi F, Confortini M, Palma P, et al. Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial. BMC Infect Dis. 2013;13(1):238.PubMedPubMedCentralCrossRef Baussano I, Franceschi S, Gillio-Tos A, Carozzi F, Confortini M, Palma P, et al. Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial. BMC Infect Dis. 2013;13(1):238.PubMedPubMedCentralCrossRef
9.
go back to reference Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings. J Infect Dis. 2010;202(12):1789–99.PubMedCrossRef Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings. J Infect Dis. 2010;202(12):1789–99.PubMedCrossRef
10.
go back to reference Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJF, Vaccarella S, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366(9490):991–8.PubMedCrossRef Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJF, Vaccarella S, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366(9490):991–8.PubMedCrossRef
11.
go back to reference Bosch FX, Qiao Y-L, Castellsagué X. CHAPTER 2 The epidemiology of human papillomavirus infection and its association with cervical cancer. Int J Gynecol Obstet. 2006;94:S8–21.CrossRef Bosch FX, Qiao Y-L, Castellsagué X. CHAPTER 2 The epidemiology of human papillomavirus infection and its association with cervical cancer. Int J Gynecol Obstet. 2006;94:S8–21.CrossRef
12.
go back to reference Janicek MF, Averette HE. Cervical cancer: prevention, diagnosis, and therapeutics. CA Cancer J Clin. 2001;51(2):92–114.PubMedCrossRef Janicek MF, Averette HE. Cervical cancer: prevention, diagnosis, and therapeutics. CA Cancer J Clin. 2001;51(2):92–114.PubMedCrossRef
13.
go back to reference Dabić MM, Hlupić L, Babić D, Jukić S, Seiwerth S. Comparison of polymerase chain reaction and catalyzed signal amplification in situ hybridization methods for human papillomavirus detection in paraffin-embedded cervical preneoplastic and neoplastic lesions. Arch Med Res. 2004;35(6):511–6.PubMedCrossRef Dabić MM, Hlupić L, Babić D, Jukić S, Seiwerth S. Comparison of polymerase chain reaction and catalyzed signal amplification in situ hybridization methods for human papillomavirus detection in paraffin-embedded cervical preneoplastic and neoplastic lesions. Arch Med Res. 2004;35(6):511–6.PubMedCrossRef
14.
go back to reference Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, et al. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol. 2004;42(7):3176–84.PubMedPubMedCentralCrossRef Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, et al. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol. 2004;42(7):3176–84.PubMedPubMedCentralCrossRef
15.
go back to reference Attoh S, Asmah R, Wiredu EK, Gyasi R, Tettey Y. Human papilloma virus genotypes in Ghanaian women with cervical carcinoma. East Afr Med J. 2010;87(8):345–9.PubMed Attoh S, Asmah R, Wiredu EK, Gyasi R, Tettey Y. Human papilloma virus genotypes in Ghanaian women with cervical carcinoma. East Afr Med J. 2010;87(8):345–9.PubMed
16.
go back to reference Bosch FX, de Sanjosé S. Chapter 1: Human Papillomavirus and Cervical Cancer—burden and assessment of causality. JNCI Monogr. 2003;2003(31):3–13.CrossRef Bosch FX, de Sanjosé S. Chapter 1: Human Papillomavirus and Cervical Cancer—burden and assessment of causality. JNCI Monogr. 2003;2003(31):3–13.CrossRef
17.
go back to reference Adjorlolo-Johnson G, Unger ER, Boni-Ouattara E, Touré-Coulibaly K, Maurice C, Vernon SD, et al. Assessing the relationship between HIV infection and cervical cancer in Côte d’Ivoire: A case-control study. BMC Infect Dis. 2010;10(1):242.PubMedPubMedCentralCrossRef Adjorlolo-Johnson G, Unger ER, Boni-Ouattara E, Touré-Coulibaly K, Maurice C, Vernon SD, et al. Assessing the relationship between HIV infection and cervical cancer in Côte d’Ivoire: A case-control study. BMC Infect Dis. 2010;10(1):242.PubMedPubMedCentralCrossRef
18.
go back to reference Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa: Cervical Cancer in sub-Saharan Africa. International Journal of Cancer [Internet]. 2013 Aug [cited 2013 Aug 19]; Available from: http://doi.wiley.com/10.1002/ijc.28425 Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa: Cervical Cancer in sub-Saharan Africa. International Journal of Cancer [Internet]. 2013 Aug [cited 2013 Aug 19]; Available from: http://​doi.​wiley.​com/​10.​1002/​ijc.​28425
19.
go back to reference Piras F, Piga M, De Montis A, Zannou AR, Minerba L, Perra MT, et al. Prevalence of human papillomavirus infection in women in Benin, West Africa. Virol J. 2011;8(1):514.PubMedPubMedCentralCrossRef Piras F, Piga M, De Montis A, Zannou AR, Minerba L, Perra MT, et al. Prevalence of human papillomavirus infection in women in Benin, West Africa. Virol J. 2011;8(1):514.PubMedPubMedCentralCrossRef
20.
go back to reference Didelot-Rousseau M-N, Nagot N, Costes-Martineau V, Vallès X, Ouedraogo A, Konate I, et al. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer. 2006;95(3):355–62.PubMedPubMedCentralCrossRef Didelot-Rousseau M-N, Nagot N, Costes-Martineau V, Vallès X, Ouedraogo A, Konate I, et al. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer. 2006;95(3):355–62.PubMedPubMedCentralCrossRef
21.
go back to reference Mayaud P, Weiss HA, Lacey CJN, Gill DK, Mabey DCW. Genital Human Papillomavirus Genotypes in Northwestern Tanzania. J Clin Microbiol. 2003;41(9):4451–3.PubMedPubMedCentralCrossRef Mayaud P, Weiss HA, Lacey CJN, Gill DK, Mabey DCW. Genital Human Papillomavirus Genotypes in Northwestern Tanzania. J Clin Microbiol. 2003;41(9):4451–3.PubMedPubMedCentralCrossRef
22.
go back to reference Castellsagué X, Menéndez C, Loscertales M-P, Kornegay JR, dos Santos F, Gómez-Olivé FX, et al. Human papillomavirus genotypes in rural Mozambique. Lancet. 2001;358(9291):1429–30.PubMedCrossRef Castellsagué X, Menéndez C, Loscertales M-P, Kornegay JR, dos Santos F, Gómez-Olivé FX, et al. Human papillomavirus genotypes in rural Mozambique. Lancet. 2001;358(9291):1429–30.PubMedCrossRef
23.
go back to reference Liaw KL, Hsing AW, Schiffman MH, You SL, Zhang T, Burk R, et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women. Int J Cancer. 1997;73(5):775–6.PubMedCrossRef Liaw KL, Hsing AW, Schiffman MH, You SL, Zhang T, Burk R, et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women. Int J Cancer. 1997;73(5):775–6.PubMedCrossRef
24.
go back to reference Conesa-Zamora P, Ortiz-Reina S, Moya-Biosca J, Doménech-Peris A, Orantes-Casado F, Pérez-Guillermo M, et al. Genotype distribution of human papillomavirus (HPV) and co-infections in cervical cytologic specimens from two outpatient gynecological clinics in a region of southeast Spain. BMC Infect Dis. 2009;9(1):124.PubMedPubMedCentralCrossRef Conesa-Zamora P, Ortiz-Reina S, Moya-Biosca J, Doménech-Peris A, Orantes-Casado F, Pérez-Guillermo M, et al. Genotype distribution of human papillomavirus (HPV) and co-infections in cervical cytologic specimens from two outpatient gynecological clinics in a region of southeast Spain. BMC Infect Dis. 2009;9(1):124.PubMedPubMedCentralCrossRef
25.
go back to reference Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. N Engl J Med. 2003;348(6):518–27.PubMedCrossRef Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. N Engl J Med. 2003;348(6):518–27.PubMedCrossRef
26.
go back to reference Martín P, Kilany L, García D, López-García AM, Martín-Azaña MJ, Abraira V, et al. Human papillomavirus genotype distribution in Madrid and correlation with cytological data. BMC Infect Dis. 2011;11(1):316.PubMedPubMedCentralCrossRef Martín P, Kilany L, García D, López-García AM, Martín-Azaña MJ, Abraira V, et al. Human papillomavirus genotype distribution in Madrid and correlation with cytological data. BMC Infect Dis. 2011;11(1):316.PubMedPubMedCentralCrossRef
27.
go back to reference Kahn JA. HPV Vaccination for the Prevention of Cervical Intraepithelial Neoplasia. N Engl J Med. 2009;361(3):271–8.PubMedCrossRef Kahn JA. HPV Vaccination for the Prevention of Cervical Intraepithelial Neoplasia. N Engl J Med. 2009;361(3):271–8.PubMedCrossRef
28.
go back to reference Dunne EF, Datta SD, Markowitz EL. A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US. Cancer. 2008;113(S10):2995–3003.PubMedCrossRef Dunne EF, Datta SD, Markowitz EL. A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US. Cancer. 2008;113(S10):2995–3003.PubMedCrossRef
29.
go back to reference Zsikla V, Baumann M, Cathomas G. Effect of buffered formalin on amplification of DNA from paraffin wax embedded small biopsies using real-time PCR. J Clin Pathol. 2004;57(6):654–6.PubMedPubMedCentralCrossRef Zsikla V, Baumann M, Cathomas G. Effect of buffered formalin on amplification of DNA from paraffin wax embedded small biopsies using real-time PCR. J Clin Pathol. 2004;57(6):654–6.PubMedPubMedCentralCrossRef
30.
go back to reference Unger ER, Vernon SD, Lee DR, Miller DL, Reeves WC. Detection of human papillomavirus in archival tissues. Comparison of in situ hybridization and polymerase chain reaction. J Histochem Cytochem. 1998;46(4):535–40.PubMedCrossRef Unger ER, Vernon SD, Lee DR, Miller DL, Reeves WC. Detection of human papillomavirus in archival tissues. Comparison of in situ hybridization and polymerase chain reaction. J Histochem Cytochem. 1998;46(4):535–40.PubMedCrossRef
31.
go back to reference An SF, Fleming KA. Removal of inhibitor(s) of the polymerase chain reaction from formalin fixed, paraffin wax embedded tissues. J Clin Pathol. 1991;44(11):924–7.PubMedPubMedCentralCrossRef An SF, Fleming KA. Removal of inhibitor(s) of the polymerase chain reaction from formalin fixed, paraffin wax embedded tissues. J Clin Pathol. 1991;44(11):924–7.PubMedPubMedCentralCrossRef
Metadata
Title
Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana
Authors
A. K. Awua
S. T. Sackey
Y. D. Osei
R. H. Asmah
E. K. Wiredu
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Infectious Agents and Cancer / Issue 1/2016
Electronic ISSN: 1750-9378
DOI
https://doi.org/10.1186/s13027-016-0050-4

Other articles of this Issue 1/2016

Infectious Agents and Cancer 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine